Impact of 4PCP on Practitioner and Patient Outcomes

Summary

Reducing opioid prescribing and improving outcomes in patients with chronic pain would benefit our nation. Neither addiction nor chronic pain spares any race, gender, or particular socio-economic status. This study is investigating a potentially inexpensive way of providing a previously costly service (the intensive chronic pain rehabilitation program), which is why insurers stopped covering it. Although it is unusual for an application from an academic institution to include a startup company (PainSTakers, LLC) as the curriculum provider, this is actually a long-term strength of this program, and the reason NIH recommended this route. It ensures that 4PCP will ultimately sustain itself rather than require government support for its continuation. Support for this application is not to provide the curriculum, but to determine if it is effective in the outcomes expected to be found. The curriculum is being provided freely only as an incentive for practitioners to participate in the research portion of the study. If the study is able to demonstrate its clinical effectiveness, the next step will be to show a positive economic impact for health care institutions and for health insurers who may then wish to support the program for their practitioners and their patients.

Conditions

• Chronic Pain

Interventions

BEHAVIORAL

4PCP Course

4PCP is a training framework for the management of chronic pain and gives practitioners lasting knowledge on how to better care for chronic pain patients.

Sponsors & Collaborators

• Medical College of Wisconsin

  collaborator OTHER

• Case Western Reserve University

  collaborator OTHER

• SSM Health

  collaborator OTHER

• Wisconsin Research and Education Network

  collaborator NETWORK

• Agency for Healthcare Research and Quality (AHRQ)

  collaborator FED

• Virginia Commonwealth University

  lead OTHER

Principal Investigators

• Thomas Chelimsky, M.D. · VCU

Study Design

Allocation

NA

Purpose

OTHER

Masking

NONE

Model

SINGLE_GROUP

Eligibility

Min Age

14 Years

Max Age

80 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2023-03-17

Primary Completion

2027-09-30

Completion

2027-09-30

Countries

• United States

Study Locations